Search
for
Sort by
Research 271–300 of 473
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- The childbearing years: hair diseases
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Alopecia Areata
- Book Reviews
- BOOK REVIEWS
- AMERICAN SOCIETY FOR DERMATOLOGIC SURGERY, INC.
- American Academy of Dermatology
- Clinical Predictors of Outcome in Nonsegmental Vitiligo: A Prospective Cohort Study
- Bhangra: Therapeutic and Pharmacological Actions in Shayb (Premature Greying of Hair)
- Platelet-Rich Plasma Contains High Concentrations of DKK1, A Potent Inhibitor of Wnt Signaling that Limits Bone Regeneration and Hair Growth
- A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital
- Issue Information ‐ TOC
- PULSED ADMINISTRATION OF CORTICOSTEROIDS IN THE TREATMENT OF ALOPECIA AREATA
- Pseudo Alopecia Areata Caused by Skull‐caps with Metal Pin Fasteners used by Orthodox Jews in Israel
- Dermatophyte infection encircling vitiligo
- Narrow-Band Ultraviolet B Phototherapy in Vitiligo
- [Acitretine].
- Phototherapy with Topical Minoxidil in Vitiligo: A Randomized Control Trial
- Diphenylcyclopropenone in severe alopecia areata in children and adolescents: long-term follow-up and relapse rate
- Comparison of Efficacy of Topical Betamethasone Dipropionate and Topical Minoxidil in Patients With Alopecia Areata
- Principles of Topical Therapy
- 308-nm excimer laser therapy in alopecia areata
- Vitiligo and alopecia areata: apples and oranges?
- Single hair grafting for the treatment of vitiligo
- Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata
- A review of monochromatic light devices for the treatment of alopecia areata
- Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring